(E)-N-hydroxy-3-(3-(((9-ethyl-2-morpholino-9H-purin-6-yl)amino)methyl)phenyl)acrylamide

ID: ALA4549278

Chembl Id: CHEMBL4549278

PubChem CID: 155550660

Max Phase: Preclinical

Molecular Formula: C21H25N7O3

Molecular Weight: 423.48

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCn1cnc2c(NCc3cccc(/C=C/C(=O)NO)c3)nc(N3CCOCC3)nc21

Standard InChI:  InChI=1S/C21H25N7O3/c1-2-27-14-23-18-19(24-21(25-20(18)27)28-8-10-31-11-9-28)22-13-16-5-3-4-15(12-16)6-7-17(29)26-30/h3-7,12,14,30H,2,8-11,13H2,1H3,(H,26,29)(H,22,24,25)/b7-6+

Standard InChI Key:  RSHKUDAKRMLDCT-VOTSOKGWSA-N

Alternative Forms

1. Parent:

   

   ALA4549278

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 423.48

Molecular Weight (Monoisotopic): 423.2019

AlogP: 1.81

#Rotatable Bonds: 7

Polar Surface Area: 117.43

Molecular Species: NEUTRAL

HBA: 9

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.56

CX Basic pKa: 5.06

CX LogP: 2.00

CX LogD: 1.99

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.30

Np Likeness Score: -1.08

References

1. Yu Y, Ran D, Jiang J, Pan T, Dan Y, Tang Q, Li W, Zhang L, Gan L, Gan Z..  (2019)  Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2.,  29  (16): [PMID:31272794] [10.1016/j.bmcl.2019.06.059]

Source

Source(1):

• Scientific Literature